Adial Pharmaceuticals Files 8-K on Accountant Change
Ticker: ADIL · Form: 8-K · Filed: May 1, 2025 · CIK: 1513525
| Field | Detail |
|---|---|
| Company | Adial Pharmaceuticals, Inc. (ADIL) |
| Form Type | 8-K |
| Filed Date | May 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, 8-k
Related Tickers: ADIL
TL;DR
ADIL changed accountants, filing 8-K on 4/28/25.
AI Summary
Adial Pharmaceuticals, Inc. filed an 8-K on May 1, 2025, reporting changes in its certifying accountant. The company, incorporated in Delaware, is located in Glen Allen, VA, with its principal executive offices at 4870 Sadler Road, Ste 300. The filing date indicates the earliest event reported was April 28, 2025.
Why It Matters
Changes in a company's certifying accountant can signal potential issues with financial reporting or internal controls, warranting investor attention.
Risk Assessment
Risk Level: low — This filing pertains to a change in the company's auditor, which is a standard procedural disclosure and does not inherently indicate financial distress or significant operational changes.
Key Players & Entities
- Adial Pharmaceuticals, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Glen Allen, VA (location) — Principal executive offices location
- April 28, 2025 (date) — Date of earliest event reported
- May 1, 2025 (date) — Filing date
FAQ
What is the primary reason for this 8-K filing?
This 8-K filing is primarily to report changes in the registrant's certifying accountant.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is April 28, 2025.
In which state is Adial Pharmaceuticals, Inc. incorporated?
Adial Pharmaceuticals, Inc. is incorporated in Delaware.
What is the address of Adial Pharmaceuticals, Inc.'s principal executive offices?
The address of Adial Pharmaceuticals, Inc.'s principal executive offices is 4870 Sadler Road, Ste 300, Glen Allen, VA 23060.
What is the Commission File Number for Adial Pharmaceuticals, Inc.?
The Commission File Number for Adial Pharmaceuticals, Inc. is 001-38323.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 1, 2025 regarding ADIAL PHARMACEUTICALS, INC. (ADIL).